Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Treatment of spinal cord injury with biomaterials and stem cell therapy in non-human primates and humansOlaya, Ana Milena Silva ; Almeida, Fernanda Martins ; Martinez, Ana Maria Blanco ; Marques, Suelen AdrianiNeural regeneration research, 2025-02, Vol.20 (2), p.343-353 [Periódico revisado por pares]India: Wolters Kluwer Medknow PublicationsTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Human-induced pluripotent stem cell-derived neural stem cell exosomes improve blood-brain barrier function after intracerebral hemorrhage by activating astrocytes via PI3K/AKT/MCP-1 axisWang, Conglin ; Cheng, Fangyuan ; Han, Zhaoli ; Yan, Bo ; Liao, Pan ; Yin, Zhenyu ; Ge, Xintong ; Li, Dai ; Zhong, Rongrong ; Liu, Qiang ; Chen, Fanglian ; Lei, PingNeural regeneration research, 2025-02, Vol.20 (2), p.518-532 [Periódico revisado por pares]India: Wolters Kluwer Medknow PublicationsTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Efficacy and safety of hepatitis B vaccine: an umbrella review of meta-analysesQiu, Jiamin ; Zhang, Shiwen ; Feng, Yonghui ; Su, Xin ; Cai, Jun ; Chen, Shiyun ; Liu, Jiazi ; Huang, Shiqi ; Huang, Haokun ; Zhu, Sui ; Wen, Huiyan ; Li, Jiaxin ; Yan, Haoyu ; Diao, Zhiquan ; Liang, Xiaofeng ; Zeng, FangfangExpert review of vaccines, 2024-12, Vol.23 (1), p.69-81 [Periódico revisado por pares]England: Taylor & Francis GroupTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Modelling the population-level benefits and cost-effectiveness of cell-based quadrivalent influenza vaccine for children and adolescents aged 6 months to 17 years in the USPelton, Stephen I ; Mould-Quevedo, Joaquin F ; Nguyen, Van HungExpert review of vaccines, 2024-12, Vol.23 (1), p.82-87 [Periódico revisado por pares]England: Taylor & Francis GroupTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Predicted serotype-specific effectiveness of pneumococcal conjugate vaccines V114 and PCV20 against invasive pneumococcal disease in childrenRyman, Josiah ; Sachs, Jeffrey R ; Yee, Ka Lai ; Banniettis, Natalie ; Weaver, Jessica ; Weiss, ThomasExpert review of vaccines, 2024-12, Vol.23 (1), p.60-68 [Periódico revisado por pares]England: Taylor & Francis GroupTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Modelling the Potential Public Health Impact of Different COVID-19 Vaccination Strategies with an Adapted Vaccine in SingaporeThakkar, Karan ; Spinardi, Julia ; Kyaw, Moe H ; Yang, Jingyan ; Mendoza, Carlos Fernando ; Ozbilgili, Egemen ; Taysi, Bulent ; Dodd, Josie ; Yarnoff, Ben ; Oh, Helen MExpert review of vaccines, 2024-12, Vol.23 (1), p.16-26 [Periódico revisado por pares]England: Taylor & Francis GroupTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Real world evidence for public health decision-making on vaccination policies: perspectives from an expert roundtablede Waure, Chiara ; Gärtner, Barbara C ; Lopalco, Pier Luigi ; Puig-Barbera, Joan ; Nguyen-Van-Tam, Jonathan SExpert review of vaccines, 2024-12, Vol.23 (1), p.27-38 [Periódico revisado por pares]England: Taylor & Francis GroupTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Influenza B virus neuraminidase: a potential target for next-generation vaccines?Do, Thi Hoai Thu ; Wheatley, Adam K ; Kent, Stephen J ; Koutsakos, MariosExpert review of vaccines, 2024-12, Vol.23 (1), p.39-48 [Periódico revisado por pares]England: Taylor & Francis GroupTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Pre-erythrocytic malaria vaccines: RTS,S, R21, and beyondHammershaimb, Elizabeth Adrianne ; Berry, Andrea AExpert review of vaccines, 2024-12, Vol.23 (1), p.49-52 [Periódico revisado por pares]England: Taylor & Francis GroupTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Research progress on the quality control of mRNA vaccinesHu, Chaoying ; Bai, Yu ; Liu, Jianyang ; Wang, Yiping ; He, Qian ; Zhang, Xuanxuan ; Cheng, Feiran ; Xu, Miao ; Mao, Qunying ; Liang, ZhenglunExpert review of vaccines, 2024-12, Vol.23 (1), p.570-583 [Periódico revisado por pares]England: Taylor & Francis GroupTexto completo disponível |